Locus Biosciences lands $20M upfront, could earn nearly $800M in licensing deal
A new licensing deal means $20 million up front and as much as $798 million in potential future payments for RTP-based Locus Biosciences.
Read MorePosted by WRAL TechWire | Jan 3, 2019
A new licensing deal means $20 million up front and as much as $798 million in potential future payments for RTP-based Locus Biosciences.
Read MorePosted by WRAL News | Dec 10, 2018
A number of companies today are using CRISPR in research platforms with the goal of harnessing the power to rewrite DNA.
Read MorePosted by WRAL News | Nov 27, 2018
Esteemed academic Vivek Wadhwa says we are entering an era of designer babies. Scientists will soon be able to edit human embryos with the aim of eliminating debilitating disease, selecting physical traits such as skin and eye color, or even adding extra intelligence. Find out more what he has to say here.
Read MorePosted by WRAL News | Aug 22, 2018
RTP-based Cell Microsystems makes first sale of its cell imaging, sorting and isolation of cells.
Read MorePosted by WRAL TechWire | Jul 24, 2018
Locus Biosciences has raised $7 million in new capital to fund the acquisition of a California firm, EpiBiome.
Read MorePosted by WRAL TechWire | Jul 17, 2018
Locus Biosciences is a fast-emerging North Carolina biotechnology company that’s about to get a lot faster at unfolding its Pac-Man-like genetic tricks to whack drug-resistant bacteria.
Read MorePosted by WRAL TechWire | Apr 6, 2018
Element Genomics, a three-year-old Duke University spin-off focusing on genomic research, has been acquired by Belgium-based UCB for as much as $30 million.
Read MorePosted by WRAL TechWire | Feb 2, 2018
LaunchBio’s second “Larger Than Life” networking event and forum on Thursday night drew a big, diverse crowd that enjoyed mixing as well as sitting in on panel discussions and even sampling some insect food. Check out our photo story.
Read MorePosted by WRAL TechWire | Jan 2, 2018
What’s coming in 2018 for the life science ecosystem? Joan Siefert Rose, CEO of LaunchBio, offers a preview.
Read More